CollPlant Biotechnologies Ltd. (CLGN)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Oct 09, 16:00
3.61
+0.10
(+2.85%)
After-Hours: 20:00
CollPlant Biotechnologies Net Income (Quarterly) : -2.726M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.726M |
| March 31, 2026 | -3.097M |
| December 31, 2025 | -3.207M |
| September 30, 2025 | -3.483M |
| June 30, 2025 | -3.347M |
| March 31, 2025 | -1.452M |
| December 31, 2024 | -3.878M |
| September 30, 2024 | -4.326M |
| June 30, 2024 | -4.21M |
| March 31, 2024 | -4.195M |
| December 31, 2023 | -4.689M |
| September 30, 2023 | -4.377M |
| June 30, 2023 | 5.762M |
| March 31, 2023 | -3.715M |
| December 31, 2022 | -4.401M |
| September 30, 2022 | -4.379M |
| June 30, 2022 | -4.285M |
| March 31, 2022 | -3.86M |
| December 31, 2021 | -3.772M |
| September 30, 2021 | -3.077M |
| June 30, 2021 | -3.038M |
| March 31, 2021 | 10.12M |
| December 31, 2020 | -2.905M |
| September 30, 2020 | 0.703M |
| June 30, 2020 | -1.971M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -3.177M |
| June 30, 2019 | -1.248M |
| March 31, 2019 | -2.038M |
| December 31, 2018 | 1.02M |
| September 30, 2018 | -1.334M |
| June 30, 2018 | -1.559M |
| March 31, 2018 | -2.092M |
| December 31, 2017 | -1.684M |
| September 30, 2017 | -1.104M |
| June 30, 2017 | -1.628M |
| March 31, 2017 | -1.393M |
| December 31, 2016 | -1.840M |
| September 30, 2016 | -1.795M |
| June 30, 2016 | -1.675M |
| March 31, 2016 | -1.952M |
| December 31, 2015 | -0.9953M |
| September 30, 2015 | -1.169M |
| June 30, 2015 | -0.9963M |
| March 31, 2015 | -0.8783M |
| December 31, 2014 | -0.9254M |
| September 30, 2014 | -0.7628M |
| June 30, 2014 | -0.866M |
| March 31, 2014 | -1.086M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -14.84M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.108M |
| Total Expenses (Quarterly) | 2.834M |
| EPS Diluted (Quarterly) | -1.890 |
| Enterprise Value | 4.779M |
| Gross Profit Margin (Quarterly) | -604.6% |
| Profit Margin (Quarterly) | -2.52K% |
| Earnings Yield | -75.19% |
| Normalized Earnings Yield | -75.19 |